Your browser doesn't support javascript.
loading
Total body fluid is the factor that affects the pharmacokinetics of tolvaptan, and its efficacy, in acute worsening heart failure patients.
Kato, Takahiro; Yasuda, Yoko; Okamoto, Hitomi; Saito, Yuji; Nakano, Yusuke; Matsuura, Katsuhiko; Oonishi, Masafumi; Amano, Tetsuya.
Afiliação
  • Kato T; Department of Pharmacy, Aichi Medical University Hospital, Nagakute, Japan.
  • Yasuda Y; Yamakawa Kids Clinic, Nagoya, Japan.
  • Okamoto H; Department of Pharmacy, Aichi Medical University Hospital, Nagakute, Japan.
  • Saito Y; Department of Pharmacy, Aichi Medical University Hospital, Nagakute, Japan.
  • Nakano Y; Department of Cardiology, Aichi Medical University, Nagakute, Japan.
  • Matsuura K; Pharmaceutical Health Care and Sciences Aichi Gakuin University School of Pharmacy, Nagoya, Japan.
  • Oonishi M; Department of Pharmacy, Aichi Medical University Hospital, Nagakute, Japan.
  • Amano T; Department of Cardiology, Aichi Medical University, Nagakute, Japan.
Pharmacol Res Perspect ; 11(3): e01088, 2023 06.
Article em En | MEDLINE | ID: mdl-37102627
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Líquidos Corporais / Insuficiência Cardíaca Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Líquidos Corporais / Insuficiência Cardíaca Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2023 Tipo de documento: Article